Company: PTPI
Filing Date: 2025-03-07
Form Type: PRE 14A
Source: 0001104659-25-021794
Chunk: 103

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-07
Form: PRE 14A
Chunk 103
---
 vesting of any other Award and delivery of shares upon such exercise or vesting (including pursuant to dividends and Dividend
Equivalents), as applicable on such terms as the Committee shall determine, including the right to require that in the event of any such
rescission, (i) the Participant shall return to the Company the shares received upon the exercise of any Option or SAR and/or the
vesting and payment of any other Award (including pursuant to dividends and Dividend Equivalents) or, (ii) if the Participant no
longer owns the shares, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of any
sale or other disposition of the shares (or, in the event the Participant transfers the shares by gift or otherwise without consideration,
the Fair Market Value of the shares on the date of the breach of the restrictive covenant agreement or activity constituting Cause),
net of the price originally paid by the Participant for the shares. Payment by the Participant shall be made in such manner and on such
terms and conditions as may be required by the Committee. The Employer shall be entitled to set off against the amount of any such payment
any amounts otherwise owed to the Participant by the Employer. In addition, all Awards under the Plan shall be subject to any applicable
clawback or recoupment policies, share trading policies and other policies that may be implemented by the Board from time to time.

(i) . The validity, construction, interpretation and effect of the Plan and Award Agreements issued under the Plan shall be governed
and construed by and determined in accordance with the laws of the State of Delaware, without giving effect to the conflict of laws provisions
thereof.

<div align='center'>C-14</div>

ANNEX D

<div align='center'>First AMENDMENT TO
Amended and restated Petros Pharmaceuticals, Inc.
2020 Omnibus Incentive Compensation PLAN</div>

This first Amendment To amended and restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan(this “Amendment”),
effective as of August 15, 2023 is made and entered into by Petros Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such
terms in the Amended and Restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan (the “